With the clock ticking, scientists working with human embryonic stem cells were grappling Tuesday with how to use their remaining federal research funds before a court ruling forces them to bring their work to an abrupt end.
Recent Posts
- Engineered Dendritic Cells Harness Tumor EVs to Boost Cancer Immunotherapy
- Top FDA Gene and Cell Therapy News: 2025 Year-End Recap
- Fatal Complication of Stem Cell Transplants Gets Its First FDA-Approved Therapy
- The 98% mystery: Scientists just cracked the code on “junk DNA” linked to Alzheimer’s
- New method preserves iPS cells for regenerative medicine
- MIT Scientists Have Discovered a Way To Rejuvenate the Immune System
